Thynk Capital, LLC.

Total investments

18

Average round size

838K

Portfolio companies

16

Rounds per year

1.80

Lead investments

1

Follow on index

0.11

Exits

3

Areas of investment
AutomotiveBiotechnologyHealth CareMedical DeviceMedicalConstructionPharmaceuticalTherapeuticsBiopharmaClinical Trials

Summary

Thynk Capital, LLC. appeared to be the VC, which was created in 2011. The main office of represented VC is situated in the Las Vegas. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Thynk Capital, LLC., startups are often financed by Sky Ventures Group, KIZOO, Cormorant Asset Management. The meaningful sponsors for the fund in investment in the same round are Jim Mellon, Bold Capital Partners. In the next rounds fund is usually obtained by Serum Institute of India Pvt. Ltd., Johnson & Johnson Innovation u2013 JJDC, Jim Mellon.

Among the most popular portfolio startups of the fund, we may highlight X4 Pharmaceuticals, Vedantra Pharmaceuticals, KitoTech Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The fund was created by Jim Plante. Besides them, we counted 1 critical employee of this fund in our database.

The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. Opposing the other organizations, this Thynk Capital, LLC. works on 22 percentage points less the average amount of lead investments.

Show more

Investments analytics

Analytics

Total investments
18
Lead investments
1
Exits
3
Rounds per year
1.80
Follow on index
0.11
Investments by industry
  • Biotechnology (15)
  • Health Care (9)
  • Pharmaceutical (6)
  • Therapeutics (4)
  • Medical (4)
  • Show 7 more
Investments by region
  • United States (17)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Group Appearance index
0.11
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Fisker 15 Sep 2017 Automotive, Manufacturing, Electric Vehicle Early Stage Venture United States, California, Los Angeles
iviva medical 05 Mar 2021 Construction Seed 0 United States, Massachusetts, Beverly
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.